Status:
COMPLETED
Efficacy of Albendazole to Treat Intestinal Helminths and Its Effect on Gut Microflora
Lead Sponsor:
Albert Schweitzer Hospital
Conditions:
Intestinal Diseases
Helminthiasis
Eligibility:
All Genders
4-14 years
Phase:
PHASE4
Brief Summary
Albendazole is a main anti-helminth, however there is a lack of data regarding its efficacy in the school children population. The aim of this study is to evaluate the efficacy of the albendazole one ...
Eligibility Criteria
Inclusion
- presence of intestinal helminths eggs in the stool
Exclusion
- allergy to imidazole derivate
- No intestinal helminths
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01192802
Start Date
August 1 2010
End Date
July 1 2012
Last Update
January 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical research Unit of Lambaréné
Lambaréné, Moyen-Ogooué Province, Gabon, 118